|
Monday, December 13, 2021 |
|
Fujitsu Launches Global Strategic Partner Academy Program to Tackle Global IT Skills and Experience Shortage |
Fujitsu today announces an ambitious Global Strategic Partner Academy program designed to address increasingly critical skills shortages. more info >> |
|
Thursday, December 9, 2021 |
|
Fujitsu and MIT's Center for Brains, Minds, and Machines Develop AI Technology Inspired by the Human Brain Able to Recognize Unseen Data with High Accuracy |
Fujitsu Limited and the Center for Brains, Minds and Machines (CBMM) headquartered at the Massachusetts Institute of Technology (MIT) have achieved an important milestone in a joint initiative to deliver improvements in the accuracy of artificial intelligence (AI) models. more info >> |
|
Wednesday, December 8, 2021 |
|
Fujitsu Earns Top Rating from CDP in Climate Change, Water Security Categories |
Fujitsu Limited today announced that the Fujitsu Group has been selected for the CDP's A List for both climate change for the fifth year in a row and water security for the third year in a row, earning the highest rating in the CDP's evaluation of corporate activities in response to climate change and water security. more info >> |
|
Monday, December 6, 2021 |
|
Fujitsu Launches 'Global Fujitsu Distinguished Engineer' Program to Accelerate Global Business, Technology, and Human Resources Strategies with Leading Engineers |
Fujitsu today announced the launch of the Global Fujitsu Distinguished Engineer (Global FDE) program, which recognizes the contributions of top-tier engineers that not only possess exceptional world class technical capabilities but have also proven to create value to strategies and customers in Fujitsu's growth technology areas critical to its future of the business. more info >> |
|
Thursday, November 18, 2021 |
|
Fujitsu's Blockchain Solution Applied to New Water Trading Platform to Tackle Global Water Shortages |
With global water supplies under severe pressure from climate change and growing worldwide demand, Fujitsu and Botanical Water Technologies (BWT) signed an agreement and initiated the creation of a blockchain-based water trading platform, "Botanical Water Exchange" (BWX), on November 8, 2021. more info >> |
|
Fujitsu and RIKEN Claim 1st Place for MLPerf HPC Benchmark with Supercomputer Fugaku |
Fujitsu and RIKEN today announced that the supercomputer Fugaku took the first place for the CosmoFlow training application benchmark, one of the key MLPerf HPC benchmarks for large-scale machine learning processing tasks requiring capabilities of a supercomputer. more info >> |
|
Tuesday, November 16, 2021 |
|
Fujitsu and Ben-Gurion University Embark on Joint Research at New Center in Israel for Precise and Secure AI |
Fujitsu Limited and BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), have signed a three-year comprehensive joint research agreement to develop technologies and solutions to contribute to the realization of safe, real-world applications of AI and machine learning technologies. more info >> |
|
Japan's Fugaku Retains Title as World's Fastest Supercomputer for Fourth Consecutive Terms |
The supercomputer Fugaku, jointly developed by RIKEN and Fujitsu, has successfully retained the top spot for fourth consecutive terms on all four of the major high-performance computer rankings. more info >> |
|
Thursday, October 28, 2021 |
|
Fujitsu and Israeli Startup Autofleet Embark on Global Strategic Cooperation |
Fujitsu Limited and Autofleet, Ltd., providing an optimization platform for fleets, leveraging AI for demand prediction and vehicle dispatching technology, have agreed to embark on global strategic cooperation to develop sustainable logistics solutions and contribute to the resolution of issues including labor shortages in the logistics industry and environmental problems. more info >> |
|
Tuesday, October 19, 2021 |
|
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment |
Aichi Cancer Center and Fujitsu Limited today announced the development of an AI solution able to select effective medical treatment from a wide range of drugs based on patients' individual cancer types and various genomic variants. more info >> |
|
|
|